| dc.creator | Schluterman, Haley M. | |
| dc.creator | Linardos, Constance G. | |
| dc.creator | Drulia, Teresa | |
| dc.creator | Marshall, James D. | |
| dc.creator | Kearns, Gregory L. | |
| dc.date.accessioned | 2024-09-25T21:35:59Z | |
| dc.date.available | 2024-09-25T21:35:59Z | |
| dc.date.issued | 2/8/2024 | |
| dc.identifier.uri | https://doi.org/10.3389/fped.2024.1350662 | |
| dc.identifier.uri | https://repository.tcu.edu/handle/116099117/66001 | |
| dc.description | The palatability of pediatric pharmaceutical products plays a crucial role of influencing medication compliance. Rejection of unpalatable medications can potentially lead to treatment failure which can have immediate and delayed consequences. With advances in both the food and pharmaceutical industries, the systematic assessment of palatability has gained importance. Various methods such as visual analogue scales, facial hedonic scales, and facial recognition software, have been employed to assess palatability. While proven to be useful, these methods have significant limitations and may not be workable for young children. Despite these advancements, a universally accepted "gold standard" for assessing pediatric mediation palatability, recognized by drug regulatory agencies, is yet to be established. | |
| dc.language | en | |
| dc.publisher | Frontiers Media SA | |
| dc.source | FRONTIERS IN PEDIATRICS | |
| dc.title | Evaluating palatability in young children: a mini-review of relevant physiology and assessment techniques | |
| dc.type | Article | |
| dc.rights.license | CC BY 4.0 | |
| local.college | Burnett School of Medicine | |
| local.college | Harris College of Nursing and Health Sciences | |
| local.department | Burnett School of Medicine | |
| local.department | Communication Sciences and Disorders | |
| local.persons | Schluterman, Linardos, Marshall, Kearns (SOM); Drulia (COSD) | |
